{"id":46075,"date":"2024-05-27T17:22:46","date_gmt":"2024-05-27T15:22:46","guid":{"rendered":"https:\/\/capitalmind.com\/?post_type=deals&#038;p=46075"},"modified":"2024-06-06T14:58:57","modified_gmt":"2024-06-06T12:58:57","slug":"cession-dortholab-a-excent-tandtechniek-oakley-capital","status":"publish","type":"deals","link":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/","title":{"rendered":"Cession d&rsquo;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)"},"content":{"rendered":"\n<p><strong>Investec a conseill\u00e9 l&rsquo;actionnaire d&rsquo;Ortholab dans le cadre de la cession \u00e0 100% \u00e0 Excent Tandtechniek, soutenue par Oakley Capital.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-a-propos-du-deal\">A propos du deal<\/h2>\n\n\n\n<p>Ortholab, cr\u00e9\u00e9 en 1967, est un groupe de laboratoires d&rsquo;orthodontie renomm\u00e9s qui fournit des travaux techniques et des services de haute qualit\u00e9 aux orthodontistes. En mettant l&rsquo;accent sur l&rsquo;innovation et l&rsquo;excellence, Ortholab s&rsquo;est forg\u00e9 une solide r\u00e9putation dans le domaine de l&rsquo;orthodontie. Employant des techniciens exp\u00e9riment\u00e9s, l&rsquo;entreprise produit des appareils orthodontiques et des appareils de r\u00e9tention avanc\u00e9s en utilisant des technologies de pointe, y compris l&rsquo;impression 3D, afin d&rsquo;obtenir un alignement pr\u00e9cis des dents.<\/p>\n\n\n\n<p>Roelant Seijger, propri\u00e9taire et directeur d&rsquo;Ortholab, restera responsable du management des laboratoires d&rsquo;orthodontie apr\u00e8s l&rsquo;acquisition.<\/p>\n\n\n\n<p>Avec cette transaction, Excent Tandtechniek poursuit la mise en \u0153uvre de sa strat\u00e9gie de croissance ambitieuse, bas\u00e9e sur une croissance organique, une expansion \u00e0 l&rsquo;international et des fusions-acquisitions cibl\u00e9es.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-notre-role\">Notre r\u00f4le<\/h2>\n\n\n\n<p>Investec a conseill\u00e9 les actionnaires d&rsquo;Ortholab tout au long du processus de vente, avec :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gestion des n\u00e9gociations de prix<\/li>\n\n\n\n<li>Gestion de la due diligence<\/li>\n\n\n\n<li>Coordination de la phase de documentation juridique<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Investec a conseill\u00e9 l&rsquo;actionnaire d&rsquo;Ortholab dans le cadre de la cession \u00e0 100% \u00e0 Excent Tandtechniek, soutenue par Oakley Capital&#8230;.<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[16663,16652],"sector":[3768],"dealtype":[16633,3706],"clienttype":[3729],"class_list":["post-46075","deals","type-deals","status-publish","hentry","dt-cession","dt-sante","sector-healthcare-fr","dealtype-mbo-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.10 (Yoast SEO v26.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cession d&#039;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital) | Investec Business Advisory Investec Business Advisory %<\/title>\n<meta name=\"description\" content=\"Investec Business Advisory Cession d&#039;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession d&#039;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)\" \/>\n<meta property=\"og:description\" content=\"Investec Business Advisory Cession d&#039;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-06T12:58:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/\",\"name\":\"Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital) | Investec Business Advisory Investec Business Advisory %\",\"isPartOf\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\"},\"datePublished\":\"2024-05-27T15:22:46+00:00\",\"dateModified\":\"2024-06-06T12:58:57+00:00\",\"description\":\"Investec Business Advisory Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)\",\"breadcrumb\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/working.capitalmind.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession d&#8217;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory\",\"https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital) | Investec Business Advisory Investec Business Advisory %","description":"Investec Business Advisory Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)","og_description":"Investec Business Advisory Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)","og_url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/","og_site_name":"Investec Business Advisory","article_modified_time":"2024-06-06T12:58:57+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/","url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/","name":"Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital) | Investec Business Advisory Investec Business Advisory %","isPartOf":{"@id":"https:\/\/working.capitalmind.com\/fr\/#website"},"datePublished":"2024-05-27T15:22:46+00:00","dateModified":"2024-06-06T12:58:57+00:00","description":"Investec Business Advisory Cession d'Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)","breadcrumb":{"@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-dortholab-a-excent-tandtechniek-oakley-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/working.capitalmind.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession d&#8217;Ortholab \u00e0 Excent Tandtechniek (Oakley Capital)"}]},{"@type":"WebSite","@id":"https:\/\/working.capitalmind.com\/fr\/#website","url":"https:\/\/working.capitalmind.com\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/working.capitalmind.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/working.capitalmind.com\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/working.capitalmind.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/46075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=46075"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=46075"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=46075"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=46075"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=46075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}